US Patent Issued to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, IPRASENSE, GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT on June 24 for "Method for determining the viability of cells" (French, American Inventors)

ALEXANDRIA, Va., June 25 -- United States Patent no. 12,339,215, issued on June 24, was assigned to COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES (Paris), IPRASENSE SAS (Clapiers, France) and GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT Ltd. (Stevenage, Great Britain).

"Method for determining the viability of cells" was invented by Cedric Allier (Grenoble, France), Lionel Herve (Grenoble, France), Geoffrey Esteban (Teyran, France), Martin Pisaneschi (Jacou, France) and Melissa Hill (King of Prussia, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method for determining a state of a cell, the cell being placed in a sample in contact with a culture medium, includes illuminating the s...